Advertisement

Journal of Ultrasound

, Volume 18, Issue 4, pp 423–430 | Cite as

Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement

  • Roberto Garberoglio
  • Camillo Aliberti
  • Marialuisa Appetecchia
  • Marco Attard
  • Giuseppe Boccuzzi
  • Flavio Boraso
  • Giorgio Borretta
  • Giuseppe Caruso
  • Maurilio Deandrea
  • Milena Freddi
  • Gabriella Gallone
  • Giovanni Gandini
  • Guido Gasparri
  • Carlo Gazzera
  • Ezio Ghigo
  • Maurizio Grosso
  • Paolo Limone
  • Mauro Maccario
  • Luigi Mansi
  • Alberto Mormile
  • Pier Giorgio Nasi
  • Fabio Orlandi
  • Donatella Pacchioni
  • Claudio Maurizio Pacella
  • Nicola Palestini
  • Enrico Papini
  • Maria Rosa Pelizzo
  • Andrea Piotto
  • Teresa Rago
  • Fabrizio RigantiEmail author
  • Lodovico Rosato
  • Ruth Rossetto
  • Antonio Scarmozzino
  • Stefano Spiezia
  • Ornella Testori
  • Roberto Valcavi
  • Andrea Veltri
  • Paolo Vitti
  • Matteo Zingrillo
Letter to the Editor

Introduction

Nodular thyroid disease is a very common finding in clinical practice, discovered by ultrasound (US) in about 50 % of the general population, with higher prevalence in women and in the elderly [1, 2, 3, 4].

Whereas therapeutic flowchart is quite established and shared for malignant lesions, multiple options are now available for patients presenting with benign thyroid nodules, ranging from simple clinical and US follow-up to thyroid surgery. The majority of thyroid nodules, benign by fine-needle aspiration, are asymptomatic, stable, or slow-growing over time and require no treatment.

Nevertheless, large thyroid nodules may become responsible for pressure symptoms, resulting in neck discomfort, cosmetic complaints, and decreased quality of life. Partial/total thyroid surgery has so far constituted the only therapeutic approach for these. Although surgery is widely available, highly effective, and safe in skilled centers, complications (both temporary and permanent) still...

Keywords

Thyroid Nodule Percutaneous Ethanol Injection Radioiodine Therapy Benign Thyroid Nodule Nodular Thyroid Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflict of interest

The authors (Roberto Garberoglio, Camillo Aliberti, Marialuisa Appetecchia, Marco Attard, Giuseppe Boccuzzi, Flavio Boraso, Giorgio Borretta, Giuseppe Caruso, Maurilio Deandrea, Milena Freddi, Gabriella Gallone, Giovanni Gandini, Guido Gasparri, Carlo Gazzera, Ezio Ghigo, Maurizio Grosso, Paolo Limone, Mauro Maccario, Luigi Mansi, Alberto Mormile, Pier Giorgio Nasi, Fabio Orlandi, Donatella Pacchioni, Claudio Maurizio Pacella, Nicola Palestini, Enrico Papini, Maria Rosa Pelizzo, Andrea Piotto, Teresa Rago, Fabrizio Riganti, Lodovico Rosato, Ruth Rossetto, Antonio Scarmozzino, Stefano Spiezia, Ornella Testori, Roberto Valcavi, Andrea Veltri, Paolo Vitti, Matteo Zingrillo) have no conflict of interest to disclose.

Ethical statement

The study described in this article does not contain studies with human or animal subjects performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840CrossRefPubMedGoogle Scholar
  2. 2.
    Gharib H, Papini E (2007) Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 36:707–735CrossRefPubMedGoogle Scholar
  3. 3.
    Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRefPubMedGoogle Scholar
  4. 4.
    Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P, AACE/AME/ETA Task Force on Thyroid Nodules (2010) American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 16 (suppl 1):1–43Google Scholar
  5. 5.
    Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, Pelizzo MR, Pezzullo L (2004) Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 28:271–276CrossRefPubMedGoogle Scholar
  6. 6.
    Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, Lausen I (2008) Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 393:667–673CrossRefPubMedGoogle Scholar
  7. 7.
    Meier DA, Brill DR, Becker DV, Clarke SE, Silberstein EB, Royal HD, Balon HR, Society of Nuclear Medicine (2002) Procedure guideline for therapy of thyroid disease with (131)iodine. J Nucl Med 43:856–861PubMedGoogle Scholar
  8. 8.
    Reiners C, Schneider P (2002) Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imag 29(Suppl 2):S471–S478CrossRefGoogle Scholar
  9. 9.
    Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A (2005) A outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf) 62:331–335CrossRefGoogle Scholar
  10. 10.
    Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA (2001) Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 86:5330–5336CrossRefPubMedGoogle Scholar
  11. 11.
    Hegedüs L (2009) Therapy: a new nonsurgical therapy option for benign thyroid nodules? Nat Rev Endocrinol 5:476–478CrossRefPubMedGoogle Scholar
  12. 12.
    Gharib H, Hegedüs L, Pacella CM, Baek JH, Papini E (2013) Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab 98:3949–3957CrossRefPubMedGoogle Scholar
  13. 13.
    Bandeira-Echtler E, Bergerhoff K, Richter B (2014) Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst RevGoogle Scholar
  14. 14.
    De Bernardi IC, Floridi C, Muollo A, Giacchero R, Dionigi GL, Reginelli A, Gatta G, Cantisani V, Grassi R, Brunese L, Carrafiello G (2014) Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med 119:512–520CrossRefPubMedGoogle Scholar
  15. 15.
    Fuller CW, Nguyen SA, Lohia S, Gillespie MB (2014) Radiofrequency ablation for treatment of benign thyroid nodules: systematic review. Laryngoscope 124:346–353CrossRefPubMedGoogle Scholar
  16. 16.
    Papini E, Pacella CM, Hegedüs L (2014) Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications. Eur J Endocrinol 170:R133–R146CrossRefPubMedGoogle Scholar
  17. 17.
    Paschke R, Hegedüs L, Alexander E, Valcavi R, Papini E, Gharib H (2011) Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol 7:354–361CrossRefPubMedGoogle Scholar
  18. 18.
    Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, Pacella S, Papini E (2000) Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217:673–677CrossRefPubMedGoogle Scholar
  19. 19.
    Kim YS, Rhim H, Tae K, Park DW, Kim ST (2006) Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–367CrossRefPubMedGoogle Scholar
  20. 20.
    Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, Lee D (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250CrossRefPubMedGoogle Scholar
  21. 21.
    Baek JH, Jeong HJ, Kim YS, Kwak MS, Lee D (2008) Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 18:675–676CrossRefPubMedGoogle Scholar
  22. 22.
    Spiezia S, Garberoglio R, Di Somma C, Deandrea M, Basso E, Limone PP, Milone F, Ramundo V, Macchia PE, Biondi B, Lombardi G, Colao A, Faggiano A (2007) Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. J Am Geriatr Soc 55:1478–1479CrossRefPubMedGoogle Scholar
  23. 23.
    Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, Spiezia S, Faggiano A, Colao A, Molinari F, Garberoglio R (2008) US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–791CrossRefPubMedGoogle Scholar
  24. 24.
    Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, Deandrea M, Limone PP, Macchia PE, Lombardi G, Colao A, Faggiano A (2009) Thyroid nodules and related symptoms are stably controlled 2 years after radiofrequency thermal ablation. Thyroid 19:219–225CrossRefPubMedGoogle Scholar
  25. 25.
    Baek JH, Moon WJ, Kim YS, Lee JH, Lee D (2009) Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 33:1971–1977CrossRefPubMedGoogle Scholar
  26. 26.
    Baek JH, Kim YS, Lee D, Huh JY, Lee JH (2010) Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. Am J Roentgenol 194:1137–1142CrossRefGoogle Scholar
  27. 27.
    Huh JY, Baek JH, Choi H, Kim JK, Lee JH (2012) Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session–prospective randomized study. Radiology 263:909–916CrossRefPubMedGoogle Scholar
  28. 28.
    Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, Marciello F, Marotta V, Del Prete M, Papini E, Lombardi G, Colao A, Spiezia S (2012) Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab 97:4439–4445CrossRefPubMedGoogle Scholar
  29. 29.
    Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH (2013) Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol 23:1044–1049CrossRefPubMedGoogle Scholar
  30. 30.
    Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, Giacca M, Barro E, De Manzini N, Stacul F (2014) Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol, article ID 934595Google Scholar
  31. 31.
    Cesareo R, Pasqualini V, Simeoni C, Sacchi M, Saralli E, Campagna G, Cianni R (2015) Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab 100:460–466CrossRefPubMedGoogle Scholar
  32. 32.
    Turtulici G, Orlandi D, Corazza A, Sartoris R, Derchi LE, Silvestri E, Baek JH (2014) Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol 40:1447–1452CrossRefPubMedGoogle Scholar
  33. 33.
    Sung JY, Kim YS, Choi H, Lee JH, Baek JH (2011) Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? Am J Roentgenol 196:W210–W214CrossRefGoogle Scholar
  34. 34.
    Sung JY, Baek JH, Kim KS, Lee D, Yoo H, Kim JK, Park SH (2013) Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 269:293–300CrossRefPubMedGoogle Scholar
  35. 35.
    Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH (2010) Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 34:1488–1493CrossRefPubMedGoogle Scholar
  36. 36.
    Jang SW, Baek JH, Kim JK, Sung JY, Choi H, Lim HK, Park JW, Lee HY, Park S, Lee JH (2012) How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol 81:905–910CrossRefPubMedGoogle Scholar
  37. 37.
    Sung JY, Baek JH, Jung SL, Kim JH, Kim KS, Lee D, Kim WB, Na DG (2015) Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid 25:112–117CrossRefPubMedGoogle Scholar
  38. 38.
    Chianelli M, Bizzarri G, Todino V, Misischi I, Bianchini A, Graziano F, Guglielmi R, Pacella CM, Gharib H, Papini E (2014) Laser ablation and 131Iodine: a 24-month pilot study of combined treatment for large toxic nodular goitre. J Clin Endocrinol Metab 99:E1283–E1286CrossRefPubMedGoogle Scholar
  39. 39.
    Monchik JM, Donatini G, Iannuccilli J, Dupuy DE (2006) Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296–304PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Baek JH, Kim YS, Sung JY, Choi H, Lee JH (2011) Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol 197:W331–W336CrossRefGoogle Scholar
  41. 41.
    Park KW, Shin JH, Han BK, Ko EY, Chung JH (2011) Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol 18:2564–2568CrossRefPubMedGoogle Scholar
  42. 42.
    Lim HK, Baek JH, Lee JH, Kim WB, Kim TY, Shong YK, Hong SJ (2015) Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol 25:163–170CrossRefPubMedGoogle Scholar
  43. 43.
    Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, Baek SM, Kim YS, Shin JH, Park JS, Kim DW, Kim JH, Kim EK, Jung SL, Na DG, Korean Society of Thyroid Radiology (2012) Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology 262:335–342CrossRefPubMedGoogle Scholar
  44. 44.
    Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, Kim EK, Lee JH, Kim DW, Park JS, Kim KS, Baek SM, Lee Y, Chong S, Sim JS, Huh JY, Bae JI, Kim KT, Han SY, Bae MY, Kim YS, Baek JH, Korean Society of Thyroid Radiology (KSThR), Korean Society of Radiologys (2012) Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 13:117–125PubMedCentralCrossRefPubMedGoogle Scholar
  45. 45.
    NIH National Institutes of Health. Consensus Development Program. http://consensus.nih.gov. Accessed 17 Feb 2012
  46. 46.
    ANAES Agence Nationale d’Accréditation et d’Évaluation en Santé (1999) Les Conférences de consensus. Base méthodologique pour leur réalisation en FranceGoogle Scholar
  47. 47.
    Candiani G, Colombo C, Daghini R, Magrini N, Mosconi P, Nonino F, Satolli R (2013) Manuale metodologico. Come organizzare una conferenza di consenso. http://www.snlg-iss.it/manuale_metodologico_consensus. Accessed 17 Feb 2012
  48. 48.
    Zingrillo M, Modoni S, Conte M, Frusciante V, Trischitta V (2003) Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules. J Nucl Med 44:207–210PubMedGoogle Scholar
  49. 49.
    Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35CrossRefPubMedGoogle Scholar
  50. 50.
    Rogers H (2013) Do low grade thyroid cancers really require thyroidectomy? BMJ 347:f5734CrossRefPubMedGoogle Scholar
  51. 51.
    Brito JP, Hay ID, Morris JC (2014) Low risk papillary thyroid cancer. BMJ 348:g3045CrossRefPubMedGoogle Scholar
  52. 52.
    Papini E, Guglielmi R, Gharib H, Misischi I, Graziano F, Chianelli M, Crescenzi A, Bianchini A, Valle D, Bizzarri G (2011) Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid 21:917–920PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Valcavi R, Piana S, Bortolani GS, Lai R, Barbieri V, Negro R (2013) Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid 23:1578–1582CrossRefPubMedGoogle Scholar

Copyright information

© Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB) 2015

Authors and Affiliations

  • Roberto Garberoglio
    • 1
  • Camillo Aliberti
    • 2
  • Marialuisa Appetecchia
    • 3
  • Marco Attard
    • 4
  • Giuseppe Boccuzzi
    • 5
  • Flavio Boraso
    • 6
  • Giorgio Borretta
    • 7
  • Giuseppe Caruso
    • 8
  • Maurilio Deandrea
    • 9
  • Milena Freddi
    • 10
  • Gabriella Gallone
    • 11
  • Giovanni Gandini
    • 12
  • Guido Gasparri
    • 10
  • Carlo Gazzera
    • 12
  • Ezio Ghigo
    • 1
  • Maurizio Grosso
    • 13
  • Paolo Limone
    • 9
  • Mauro Maccario
    • 1
  • Luigi Mansi
    • 14
  • Alberto Mormile
    • 9
  • Pier Giorgio Nasi
    • 15
  • Fabio Orlandi
    • 16
  • Donatella Pacchioni
    • 17
  • Claudio Maurizio Pacella
    • 18
  • Nicola Palestini
    • 10
  • Enrico Papini
    • 19
  • Maria Rosa Pelizzo
    • 20
  • Andrea Piotto
    • 20
  • Teresa Rago
    • 21
  • Fabrizio Riganti
    • 1
    Email author
  • Lodovico Rosato
    • 22
  • Ruth Rossetto
    • 1
  • Antonio Scarmozzino
    • 23
  • Stefano Spiezia
    • 24
  • Ornella Testori
    • 25
  • Roberto Valcavi
    • 26
  • Andrea Veltri
    • 27
  • Paolo Vitti
    • 21
  • Matteo Zingrillo
    • 28
  1. 1.Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, Molinette Hospital, A.O.U. Città della Salute e della Scienza di TorinoUniversity of TurinTurinItaly
  2. 2.Division of Interventional RadiologyIRCCS Istituto Oncologico VenetoPaduaItaly
  3. 3.Endocrinology UnitRegina Elena National Cancer InstituteRomeItaly
  4. 4.Division of EndocrinologyCervello HospitalPalermoItaly
  5. 5.Oncological Endocrinology Unit, Department of Medical Sciences, Molinette Hospital, A.O.U. Città della Salute e della Scienza di TorinoUniversity of TurinTurinItaly
  6. 6.ASL TO4TurinItaly
  7. 7.Division of Endocrinology, Diabetes and MetabolismSanta Croce e Carle HospitalCuneoItaly
  8. 8.Section of Radiological Sciences, Policlinico Paolo GiacconeUniversity of PalermoPalermoItaly
  9. 9.Division of Endocrinology, Diabetology and MetabolismMauriziano Umberto I HospitalTurinItaly
  10. 10.Endocrine Surgical Unit, Department of Surgery, Molinette Hospital, A.O.U. Città della Salute e della Scienza di TorinoUniversity of TurinTurinItaly
  11. 11.Endocrinology UnitSedes Sapientiae HospitalTurinItaly
  12. 12.Department of Radiology, Molinette Hospital, A.O.U. Città della Salute e della Scienza di TorinoUniversity of TurinTurinItaly
  13. 13.Department of RadiologySanta Croce e Carle HospitalCuneoItaly
  14. 14.Nuclear Medicine Unit, Department Magrassi-LanzaraSecond University of NaplesNaplesItaly
  15. 15.Surgical UnitSedes Sapientiae HospitalTurinItaly
  16. 16.Division of Internal Medicine, Department of Medical Sciences, Gradenigo HospitalUniversity of TurinTurinItaly
  17. 17.Pathology Unit, Molinette Hospital, A.O.U. Città della Salute e della Scienza di TorinoUniversity of TurinTurinItaly
  18. 18.Division of Interventional RadiologyRegina Apostolorum HospitalAlbano LazialeRome
  19. 19.Division of EndocrinologyRegina Apostolorum HospitalAlbano LazialeRome
  20. 20.Division of Surgical Pathology, Department of Medical and Surgical SciencesUniversity of PadovaPaduaItaly
  21. 21.Department of EndocrinologyUniversity of PisaPisaItaly
  22. 22.Endocrine Surgical Unit, Department of Surgery, Ivrea Hospital ASL TO4, School of MedicineUniversity of TurinTurinItaly
  23. 23.Department of Health Management, A.O.U. Città della Salute e della Scienza di TorinoUniversity of TurinTurinItaly
  24. 24.Department of General and Endocrine SurgerySan Gennaro HospitalNaplesItaly
  25. 25.Nuclear Medicine UnitSanti Antonio e Biagio e Cesare Arrigo HospitalAlessandriaItaly
  26. 26.Endocrinology UnitArcispedale Santa Maria NuovaReggio EmiliaItaly
  27. 27.Department of Radiology, San Luigi Gonzaga Hospital, OrbassanoUniversity of TurinTurinItaly
  28. 28.EndocrinologyFoggiaItaly

Personalised recommendations